BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33588148)

  • 1. Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab.
    Comito F; Nigro MC; Sperandi F; Melotti B; Ardizzoni A
    Eur J Cancer; 2021 Mar; 146():84-86. PubMed ID: 33588148
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of porocarcinoma with maxacalcitol and imiquimod.
    Nagasawa T; Hirata A; Niiyama S; Enomoto Y; Fukuda H
    Dermatol Ther; 2019 Mar; 32(2):e12830. PubMed ID: 30659720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive eccrine porocarcinoma associated with haematological disorders: report of two cases.
    Dewan P; Moir G; Cerio R; Harwood C
    Clin Exp Dermatol; 2010 Jun; 35(4):e207-9. PubMed ID: 20518919
    [No Abstract]   [Full Text] [Related]  

  • 4. Metastatic eccrine porocarcinoma successfully treated with carboplatin and epirubicin chemotherapy.
    Fukuda K; Funakoshi T; Fukuyama M; Kakuta R; Sato M; Nakamura Y; Tanese K; Masugi Y; Amagai M
    J Dermatol; 2015 Sep; 42(9):928-30. PubMed ID: 26073009
    [No Abstract]   [Full Text] [Related]  

  • 5. Resolution of Metastatic Subungal Eccrine Porocarcinoma Treated with Intralesional Interleukin-2.
    Drohan A; Melvin J; Murphy J; Giacomantonio C; Helyer L
    Curr Oncol; 2020 Dec; 28(1):220-225. PubMed ID: 33704189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of multiple bilateral primary eccrine porocarcinoma with topical diphencyprone: a case report.
    Kutty A; Harper F; Akhras V
    Br J Dermatol; 2013 Nov; 169(5):1159-61. PubMed ID: 23773127
    [No Abstract]   [Full Text] [Related]  

  • 7. A Rare Case of Eccrine Porocarcinoma of the Eyelid.
    Chua PY; Cornish KS; Stenhouse G; Barras CW
    Semin Ophthalmol; 2015; 30(5-6):443-5. PubMed ID: 24576261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after multidisciplinary management of a metastatic sarcomatoid porocarcinoma with repeated exeresis, radiotherapy, chemotherapy and cetuximab: case report and review of literature.
    Ponzetti A; Ribero S; Caliendo V; Spadi R; Macripò G; Lista P
    G Ital Dermatol Venereol; 2017 Feb; 152(1):66-70. PubMed ID: 25236317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-EGFR Therapy in Right-Sided Metastatic Colorectal Cancer: Right or Wrong?
    Weinberg BA
    J Natl Compr Canc Netw; 2018 Dec; 16(12):1547-1548. PubMed ID: 30545999
    [No Abstract]   [Full Text] [Related]  

  • 10. Eccrine porocarcinoma with extensive cutaneous metastases.
    Montes-Torres A; Pérez-Plaza A; Llamas-Velasco M; Gordillo C; De Argila D; García-García C; Fraga J; Marín A; Ballesteros AI; Daudén E
    Int J Dermatol; 2016 Mar; 55(3):e156-60. PubMed ID: 26566927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic porocarcinoma achieving complete radiological and clinical response with pembrolizumab.
    Lee KA; Cioni M; Robson A; Bataille V
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31492726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exceptional response to anti-PD-1 treatment in a patient with metastatic cutaneous hidradenocarcinoma.
    Obermann H; Schmidle P; Steimle-Grauer SA; Pfarr N; Posch C
    Eur J Cancer; 2021 Mar; 145():143-145. PubMed ID: 33465705
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sweat gland eccrine porocarcinoma of the face: a rare annexal tumor].
    Lakouichmi M; El Bouihi M; Zrara I; Lahmiti S; Hattab NM
    Pan Afr Med J; 2013; 14():135. PubMed ID: 23734280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porocarcinoma: case report.
    Cursino FD; Teixeira L; Lima Ede A; Lima Mde A; Rodrigues SC; Takano D
    An Bras Dermatol; 2011; 86(6):1201-4. PubMed ID: 22281914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary eccrine porocarcinoma of the finger with transit forearm and axillary metastasis.
    Bhat W; Akhtar S; Khotwal A; Platt AJ
    Ann Plast Surg; 2011 Apr; 66(4):344-6. PubMed ID: 21042176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eccrine porocarcinoma arising within an area of Bowen disease.
    Lowney AC; Mc Aleer MA; O'Connor K; Fitzgibbon JF; Bourke JF
    Clin Exp Dermatol; 2012 Mar; 37(2):136-8. PubMed ID: 21973218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eccrine porocarcinoma: a report of 2 cases and review of the literature.
    Nguyen A; Nguyen AV
    Cutis; 2014 Jan; 93(1):43-6. PubMed ID: 24505584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eccrine Porocarcinoma: A Wolf in Sheep's Clothing.
    Alcon A; Pandit A; Moss J; Narayan D
    Plast Reconstr Surg; 2015 Jul; 136(1):127e-128e. PubMed ID: 25803156
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of Sentinel Lymph Node Biopsy for Eccrine Porocarcinoma.
    Tsunoda K; Onishi M; Maeda F; Akasaka T; Sugai T; Amano H
    Acta Derm Venereol; 2019 Jun; 99(7):691-692. PubMed ID: 30868172
    [No Abstract]   [Full Text] [Related]  

  • 20. Eccrine porocarcinoma (malignant eccrine poroma): a series of eight challenging cases.
    Luz Mde A; Ogata DC; Montenegro MF; Biasi LJ; Ribeiro LC
    Clinics (Sao Paulo); 2010 Jul; 65(7):739-42. PubMed ID: 20668633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.